Clinical TrialsSearch results
Number of results: 978
Completed
- A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3152 in Healthy Japanese Adults
- COVID-19, SARS-CoV-2
- Ageishi Yuji
- 2023-07-12
Completed
- A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7442 in Healthy Japanese Participants
- COVID-19
- Hibi Kazushige
- 2021-03-10
Completed
- A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS
- coronavirus disease 2019(COVID-19)
- Nanki Toshihiro
- 2021-03-29
Completed
- A phase I study of TS-172 in healthy adult subjects (Single and Multiple doses)
- Healthy adult subjects
- Mita Seiji
- 2021-07-12
Completed
- A PHASE I, TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF RAY121 IN HEALTHY VOLUNTEERS
- Healthy Volunteer
- Kai Megumi
- 2022-08-04
Completed
- A phase II continuous clinical trial of peptide vaccination for cancer patients
- Malignant Tumor
- Yutani Shigeru
- 2019-03-19
Completed
- A phase II study of additional effect of palliative radiotherapy combined with immune check point inhibitors plus chemotherapy for patients with advanced non-small-cell lung cancer.
- non-small cell lung cancer
- Imaizumi Kazuyoshi
- 2020-10-27
Completed
- A Phase II study of Durvalumab (MEDI4736) plus carboplatin and etoposide in elderly patients with extensive-stage small-cell lung cancer
- extensive-stage small cell lung cancer
- Koichi Azuma
- 2021-08-05
Completed
- A phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in EGFR-mutated advanced non-small cell lung cancer
- non-small cell lung cancer
- Takayama Koichi
- 2019-07-08
Completed
- A phase II trial of osimertinib for elderly patients with advanced or postoperative recurrent non-small-cell lung cancer
- non-small cell lung cancer
- Takayama Koichi
- 2018-11-14